Capsules containing accurately weighed quantities VE-821 cost of drug loaded pellets equivalent to 200 mg of aceclofenac of each batch were taken in 900 ml dissolution

medium and drug release was studied (first 2 h in pH 1.2, hydrochloric acid buffer and the remaining in pH 6.8, phosphate buffer) at 50 rpm and at a temperature of 37 ± 0.5 °C. 5 ml of dissolution medium was withdrawn periodically at regular intervals and was replaced with same volume of fresh medium. The withdrawn sample were filtered through Whattmann filter and analyzed spectrophotometrically at 274 nm for drug release. Acute analgesia produced by drugs can be assessed by Eddy’s hot plate method. In this method heat is used as a source of pain. Rats were weighed and numbered. They were click here divided into two groups (n = 4 in each group). Group I served as standard (received aceclofenac equivalent to 10 mg/kg body weight).

Group II served as test (received formulation F6 equivalent to 10 mg/kg body weight). After pre-determined time intervals, animals of both the groups were individually placed on hot plate maintained at constant temperature (55 °C) and the reaction of animals, such as paw licking or jump response (whichever appears first) was taken as the end point and the readings were shown in Table 5. Angle of repose of uncoated pellets, drug layered pellets and polymer coated pellets were found to be 27.29, 32.17, 37.45 respectively. The drug content of aceclofenac pellet formulation was evaluated and the average percent drug content was found to be 71.16%. The release of drug from the developed formulations (F1–F6) was determined and was shown in Fig. 1. In vitro percentage drug release from pellet formulations F1–F6 using different concentrations of ethyl cellulose and hydroxyl propyl methyl cellulose showed 97.02%, 95.23%, 96.58%, 99.66%, 97.03%, 96.51% respectively. Among all, F6 was found to be the best formulation which sustains tuclazepam the drug release for 28 h. In vitro release rate of aceclofenac from formulation F6 and marketed formulation was

compared and the results were reported graphically. Based on regression values (r), all formulations followed first order kinetics and the kinetic data of coated aceclofenac pellets was reported in Table 4. From the in vitro release data obtained by dissolution studies formulation F6 was selected as optimized formulation. The dissolution profile of the optimized formulation of sustained release pellets was compared with marketed formulation shown in Fig. 2. The coatings of NPS, coated pellets and extended release pellets were studied by SEM. The morphology of pellets were observed to be smooth, rough and spherical depending upon various compositions of polymer and plasticizer and SEM photographs were shown in Fig. 3(a), (b), (c), (d). Drug polymer interactions were studied by FT-IR spectrophotometer (BRUKER). The IR-spectrum of the pellet from 3500 to 1000 cm−1 was recorded and was shown in Fig. 4.